Immunohistochemical (IHC) staining of tumor showed a PD-L1 expression < 1%, on both tumor cells and immune cells, and lack of human leukocyte antigen (HLA) class I and β2-microglobulin (β2m) expression on tumor cells (Fig. 3). This evidence concerns the gene B2M and neoplasm.